Literature DB >> 20347968

CK2 and GSK3 phosphorylation on S29 controls wild-type ATXN3 nuclear uptake.

V Pastori1, E Sangalli, P Coccetti, C Pozzi, S Nonnis, G Tedeschi, P Fusi.   

Abstract

In the present work we show that murine ATXN3 (ATXN3Q6) nuclear uptake is promoted by phosphorylation on serine 29, a highly conserved residue inside the Josephin domain. Both casein kinase 2 (CK2) and glycogen synthase kinase 3 (GSK3) are able to carry out phosphorylation on this residue. S29 phosphorylation was initially assessed in vitro on purified ATXN3Q6, and subsequently confirmed in transfected COS-7 cells, by MS analysis. Site-directed mutagenesis of S29 to an alanine was shown to strongly reduce nuclear uptake, in COS-7 transiently transfected cells overexpressing ATXN3Q6, while substitution with phospho-mimic aspartic acid restored the wild-type phenotype. Finally, treatment with CK2 and GSK3 inhibitors prevented S29 phosphorylation and strongly inhibited nuclear uptake, showing that both kinases are involved in ATXN3Q6 subcellular sorting. Although other authors have previously addressed this issue, we show for the first time that ATXN3 is phosphorylated inside the Josephin domain and that S29 phosphorylation is involved in nuclear uptake of ATXN3. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347968     DOI: 10.1016/j.bbadis.2010.03.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  The spatial and temporal organization of ubiquitin networks.

Authors:  Caroline Grabbe; Koraljka Husnjak; Ivan Dikic
Journal:  Nat Rev Mol Cell Biol       Date:  2011-03-30       Impact factor: 94.444

2.  IKKγ/NEMO Localization into Multivesicular Bodies.

Authors:  Lisa-Marie Wackernagel; Mohsen Abdi Sarabi; Sönke Weinert; Werner Zuschratter; Karin Richter; Klaus Dieter Fischer; Ruediger C Braun-Dullaeus; Senad Medunjanin
Journal:  Int J Mol Sci       Date:  2022-06-17       Impact factor: 6.208

Review 3.  Protein kinase CK2: a potential therapeutic target for diverse human diseases.

Authors:  Christian Borgo; Claudio D'Amore; Stefania Sarno; Mauro Salvi; Maria Ruzzene
Journal:  Signal Transduct Target Ther       Date:  2021-05-17

4.  Perturbation of the Akt/Gsk3-β signalling pathway is common to Drosophila expressing expanded untranslated CAG, CUG and AUUCU repeat RNAs.

Authors:  Clare L van Eyk; Louise V O'Keefe; Kynan T Lawlor; Saumya E Samaraweera; Catherine J McLeod; Gareth R Price; Deon J Venter; Robert I Richards
Journal:  Hum Mol Genet       Date:  2011-04-25       Impact factor: 6.150

Review 5.  Identifying Therapeutic Targets for Spinocerebellar Ataxia Type 3/Machado-Joseph Disease through Integration of Pathological Biomarkers and Therapeutic Strategies.

Authors:  Yu-Shuan Chen; Zhen-Xiang Hong; Shinn-Zong Lin; Horng-Jyh Harn
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

Review 6.  Protein Kinase CK2 and Its Potential Role as a Therapeutic Target in Huntington's Disease.

Authors:  Angel White; Anna McGlone; Rocio Gomez-Pastor
Journal:  Biomedicines       Date:  2022-08-15

Review 7.  Regulation of Deubiquitinating Enzymes by Post-Translational Modifications.

Authors:  Tanuza Das; Sang Chul Shin; Eun Joo Song; Eunice EunKyeong Kim
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

Review 8.  Roles of Post-translational Modifications in Spinocerebellar Ataxias.

Authors:  Linlin Wan; Keqin Xu; Zhao Chen; Beisha Tang; Hong Jiang
Journal:  Front Cell Neurosci       Date:  2018-09-19       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.